Codes / ICD10CM / H35.35

H35.35 Cystoid macular degeneration

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Cystoid Macular Degeneration

Summary

Cystoid macular degeneration is a condition characterized by the formation of cyst-like spaces in the macula, the central part of the retina responsible for sharp central vision. This can lead to swelling (edema) and progressive vision loss, often due to fluid accumulation in the retinal layers. The condition may be associated with underlying ocular or systemic factors.

Causes

The primary cause is fluid accumulation in the macula, which can result from disrupted retinal pigment epithelium function or leakage from retinal blood vessels. It may occur secondary to conditions like diabetic retinopathy, retinal vein occlusion, or as a complication of eye surgery (e.g., cataract extraction). In some cases, it is idiopathic (without a clear underlying cause).

Risk Factors

  • Underlying ocular conditions (e.g., diabetic retinopathy, uveitis).
  • Systemic diseases (e.g., diabetes, hypertension).
  • Prior eye surgeries or procedures.
  • Use of certain medications (e.g., corticosteroids).
  • Advanced age.

Symptoms

  • Blurred or distorted central vision.
  • Reduced visual acuity.
  • Difficulty reading or recognizing fine details.
  • Metamorphopsia (distorted perception of straight lines).
  • Scotomas (blind spots) in the central visual field.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing and dilated funduscopy to assess the macula. Optical coherence tomography (OCT) is used to detect cystoid spaces and retinal thickening. Fluorescein angiography may be performed to evaluate vascular leakage or underlying causes.

Treatment Options

  • Anti-VEGF injections to reduce fluid accumulation and swelling.
  • Corticosteroids (topical, periocular, or intravitreal) to manage inflammation.
  • Management of underlying conditions (e.g., glycemic control in diabetes).
  • Laser therapy in select cases to seal leaking vessels.
  • Monitoring for progression with regular OCT scans.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and timely treatment. With appropriate management, vision may stabilize or improve, but permanent damage can occur if left untreated. Regular follow-up with an ophthalmologist is essential to monitor retinal changes and adjust treatment as needed.

Complications

  • Permanent vision loss or legal blindness in severe cases.
  • Recurrence of cystoid changes.
  • Secondary complications from underlying conditions (e.g., diabetic retinopathy progression).

Lifestyle & Prevention

  • Control systemic conditions (e.g., diabetes, hypertension) to reduce risk.
  • Avoid smoking, which may exacerbate retinal damage.
  • Protect eyes from excessive UV exposure.
  • Maintain a balanced diet rich in antioxidants (e.g., leafy greens, fish).

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, such as blurring, distortion, or loss of central vision. Prompt evaluation is critical to prevent irreversible damage.

Tips for Medical Coders

Document the underlying cause (if known) and any associated procedures (e.g., injections, laser therapy) to support code specificity. Ensure clinical notes specify the eye affected (if unilateral) and any contributing factors (e.g., diabetic retinopathy) to align with documentation requirements for H35.35.

Book a walkthrough

H35.35 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.